Precision Neuroscience

Precision Neuroscience, founded in 2021, is a private, clinical-stage medical device company pioneering a less invasive approach to brain-computer interfaces. Its flagship technology, the Layer 7 Cortical Interface, is a thin-film electrode array that conforms to the brain's surface and has achieved FDA clearance and a record for electrode density in humans. The company is advancing through clinical research with major academic medical centers, has secured significant venture funding, and is building in-house manufacturing capability, positioning it as a leading competitor in the emerging high-bandwidth BCI market.

The Layer 7 Cortical Interface: a flexible, thin-film micro-electrode array placed on the brain's surface via a minimally invasive procedure, capable of high-density neural recording with thousands of channels.

Precision competes in the high-bandwidth BCI space primarily against Neuralink (penetrating electrodes) and Synchron (endovascular stent-electrode). Its key differentiator is the minimally invasive surgical approach for a surface array, aiming for a better safety profile while maintaining high channel count. The field also includes academic and earlier-stage commercial efforts.